KRT18P55

Across TCGA pan-cancer cohorts, KRT18P55 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated KRT18P55 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher KRT18P55 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRT18P55 expression acts as an unfavorable survival marker, although some lineages such as THCA and READ show a favorable association.

LUAD, PAAD, and UVM are the cancer types where KRT18P55 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Quartile	All	0.586	0.753	<.001	58	view →
PAAD	DFS	Quartile	All	0.253	0.491	.001	30	view →
UVM	OS	Tertile	III,IV	0.234	0.762	.004	30	view →
THCA	OS	Quartile	II,III,IV	1.000	0.804	.009	29	view →
MESO	OS	Median	III,IV	0.273	0.494	.001	26	view →
KIRC	DFS	Quartile	All	0.699	0.898	.005	24	view →
READ	DFS	Tertile	All	0.865	0.562	.001	24	view →
BRCA	OS	Tertile	III,IV	0.939	0.849	.007	23	view →
KICH	DFS	Tertile	II,III,IV	0.686	0.954	.017	21	view →
CHOL	DFS	Tertile	All	0.102	0.890	<.001	20	view →
LGG	DFS	Quartile	All	0.900	0.775	.001	17	view →
LIHC	OS	Tertile	III,IV	0.975	0.535	.003	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

KRT18P55–LUAD (OS)

Open the LUAD breakdown →